Aytu Biopharma Inc (NASDAQ:AYTU)
| 2.68 Delayed Data As of Sep 29 |  +0.01 / +0.37%Today’s Change | 1.38 Today|||52-Week Range 4.88 | -29.10% Year-to-Date |
| SECTOR Health Technology | INDUSTRY Pharmaceuticals: Major | MARKET CAP $5.9M |
Company Description
Aytu Biopharma, Inc. is a specialty pharmaceutical company, which focuses on identifying, acquiring, and commercializing novel products. Its products include Adzenys ER, Adzenys XR-ODT, Cotempla XR-ODT, Karbinal ER, Poly-Vi-Flor, Tri-Vi-Flor, Generic Tussionex, Tuzistra XR and ZolpiMist. The company was founded on August 9, 2002 and is headquartered in Englewood, CO.
Contact Information
Aytu Biopharma, Inc. 7900 East Union Avenue Englewood Colorado 80237 |
Employees
Shareholders
| Individual stakeholders | 5.34% |
| Other institutional | 43.97% |
| Mutual fund holders | 1.13% |
Top Executives
| Joshua R. Disbrow | Chairman & Chief Executive Officer |
| Christopher Brooke | Chief Operating Officer |
| Mark K. Oki | Chief Financial Officer, Secretary & Treasurer |
| Russell Lee McMahen | Senior Vice President-Research & Development |
| Jarrett T. Disbrow | Chief Business Officer |
